Webinar: Obesity Drugs with Dr. Sean Wharton | Dr. Curnew MD
In this prerecorded webinar, Dr. Curnew and the team interview obesity expert Dr. Sean Wharton to learn about the current state of obesity drugs including Ozempic (Semaglutide) and Trizepatide, the neurobiology of obesity, the stigma surrounding it, as well as general tips on managing obesity which is a complex chronic medical condition.
Dr. Wharton's clinic website: https://whartonmedicalclinic.com
Contact page for clinical trials patients can join at Dr. Wharton's clinic: https://whartonmedicalclinic.com/whar...
Timestamps:
00:00:00 Intro
00:01:02 Webinar objectives
00:02:00 Wharton Medical Clinic & Trials
00:03:40 Obesity as a complex condition
00:05:11 Long-term weight management
00:05:35 Neurobiology of obesity
00:09:47 Obesity & stigma
00:12:15 The 3 pillars of obesity treatment
00:12:45 How much weight loss is enough?
00:14:48 3 generations of obesity drugs
00:28:31 Body composition & muscle mass on obesity drugs
00:32:08 Weight loss without drugs
00:35:09 Ozempic for Heart Failure
00:37:04 What happens when you stop obesity drugs?
00:38:24 GLP-1 meds for fatty liver & Alzheimer's disease
00:39:51 Trials at Wharton Medical Clinic
00:41:11 Takeaways & commonly asked questions
#obesity #ozempic #mounjaro #zepbound #seanwharton #ozempicweightloss #wegovy #weightloss #weightmanagement #heartdisease #hearthealth #health #healthyeating #healthylifestyle #cardiovasculardisease #cardiovascularhealth #behealthy #gregcurnew #drcurnew
